Citations for
1APOC3, MDM2
Mdm2 is a novel activator of ApoCIII promoter which is antagonized by p53 and SHP inhibition.
Yang Z, Zhang Y, Wang L.
Biochem Biophys Res Commun 417(2):744-6. Epub 2011 Dec 16. 2012
2APOC3
Association of lipoprotein lipase and apolipoprotein C-III genes polymorphism with acute myocardial infarction in diabetic patients.
Abd El-Aziz TA, Mohamed RH, Hashem RM.
Mol Cell Biochem 354(1-2):141-50. Epub 2011 Apr 17. 2011
3APOC3
Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease.
Ooi EM, Chan DT, Watts GF, Chan DC, Ng TW, Dogra GK, Irish AB, Barrett PH.
J Lipid Res 52(4):794-800. Epub 2011 Feb 6. 2011
4APOC3
Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia.
Caron S, Verrijken A, Mertens I, Samanez CH, Mautino G, Haas JT, Duran-Sandoval D, Prawitt J, Francque S, Vallez E, Muhr-Tailleux A, Berard I, Kuipers F, Kuivenhoven JA, Biddinger SB, Taskinen MR, Van Gaal L, Staels B.
Arterioscler Thromb Vasc Biol 31(3):513-9. Epub 2010 Dec 23. 2011
5APOC3
Lowering apolipoprotein CIII delays onset of type 1 diabetes.
Holmberg R, Refai E, Hg A, Crooke RM, Graham M, Olivecrona G, Berggren PO, Juntti-Berggren L.
Proc Natl Acad Sci U S A 108(26):10685-9. Epub 2011 Jun 13. 2011
6APOC3, PPARGC1B
Regulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acid.
Hernandez C, Molusky M, Li Y, Li S, Lin JD.
Cell Metab 12(4):411-9. 2010
7APOC3
Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype.
Zheng C, Khoo C, Furtado J, Sacks FM.
Circulation 121(15):1722-34. Epub 2010 Apr 5. 2010
8APOA5, APOC3
Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS, Vlădică M, Sima AV.
Biochem Biophys Res Commun 391(1):587-91. Epub 2009 Nov 20. 2010
9APOC3
ApoC-III gene expression is sharply increased during adipogenesis and is augmented by retinoid X receptor (RXR) agonists.
Takahashi Y, Inoue J, Kagechika H, Sato R.
FEBS Lett 583(2):493-7. Epub 2008 Dec 31. 2009
10APOC3
A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.
Pollin TI, Damcott CM, Shen H, Ott SH, Shelton J, Horenstein RB, Post W, McLenithan JC, Bielak LF, Peyser PA, Mitchell BD, Miller M, O'Connell JR, Shuldiner AR.
Science 322(5908):1702-5. 2008
11APOC3, TLR2
Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation.
Kawakami A, Osaka M, Aikawa M, Uematsu S, Akira S, Libby P, Shimokado K, Sacks FM, Yoshida M.
Circ Res 103(12):1402-9. Epub 2008 Oct 30. 2008
12APOA1, APOA2, APOB, APOC1, APOC2, APOC3, APOE, CLU
Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression.
Li CM, Clark ME, Chimento MF, Curcio CA.
Invest Ophthalmol Vis Sci 47(7):3119-28. 2006
13APOC3
Susceptibility to type 1 diabetes is associated with ApoCIII gene haplotypes.
Hokanson JE, Kinney GL, Cheng S, Erlich HA, Kretowski A, Rewers M.
Diabetes 55(3):834-8. 2006
14CETP, ABCA1, LPL, APOC3, APOA4
Genetic determinants of plasma HDL-cholesterol levels in familial hypercholesterolemia.
van Aalst-Cohen ES, Jansen AC, Boekholdt SM, Tanck MW, Fontecha MR, Cheng S, Li J, Defesche JC, Kuivenhoven JA, Kastelein JJ.
Eur J Hum Genet 13(10):1137-42. 2005
15APOA1, APOA4, APOA5, APOC3, HLP5
Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia.
Eichenbaum-Voline S, Olivier M, Jones EL, Naoumova RP, Jones B, Gau B, Patel HN, Seed M, Betteridge DJ, Galton DJ, Rubin EM, Scott J, Shoulders CC, Pennacchio LA.
Arterioscler Thromb Vasc Biol 24(1):167-74. Epub 2003 Oct 09. 2004
16APOC3
Evidence of linkage of HDL level variation to APOC3 in two samples with different ascertainment.
Gagnon F, Jarvik GP, Motulsky AG, Deeb SS, Brunzell JD, Wijsman EM.
Hum Genet 113(6):522-33. Epub 2003 Aug 29. 2003
17APOC3
Interaction between the APOC3 gene promoter polymorphisms, saturated fat intake and plasma lipoproteins.
Brown S, Ordovas JM, Campos H.
Atherosclerosis 170(2):307-13. 2003
18APOA5, APOC3
Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.
Talmud PJ, Hawe E, Martin S, Olivier M, Miller GJ, Rubin EM, Pennacchio LA, Humphries SE.
Hum Mol Genet 11(24):3039-46. 2002
19APOC3
Linkage of the apo CIII microsatellite with isolated low high-density lipoprotein cholesterol.
Devlin CM, et al.
Hum Genet 102 : 273-281. 1998
20ST3, APOC3, CASP1, FDX1
A yeast artificial chromosome contig and NotI restriction map that spans the tumor suppressor gene(s) locus, 11q22.2-q23.3.
Arai Y, et al.
Genomics 35 : 196-206. 1996
21APOC3
Apolipoprotein C-III (Lys58-Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.
von Eckardstein A, et al.
J Clin Invest 87 : 1724-1731. 1991
22APOC3
Hypervariable polymorphism in the APOC3 gene.
Bhattacharya S, et al.
Nucleic Acids Res 19 : 4799. 1991
23APOC3
MicroVNTR (CTTT)n at the apo C-III locus.
Hata A, et al.
Nucleic Acids Res 19 : 5098. 1991
24APOC3
Detection of Sstl restriction site polymorphism in human APOC3 by the polymerase chain reaction.
Hixson JE, et al.
Nucleic Acids Res 19 : 196. 1991
25APOC3
Tetranucleotide repeat polymorphism in the apolipoprotein C-III gene.
Zuliani G, et al.
Nucleic Acids Res 18 : 4299. 1990
26APOC3
PvuII polymorphic site upstream to the human ApoCIII gene.
Oettgen P, et al.
Nucleic Acids Res 14 : 5571. 1986
27APOC3
Linkage studies on familial hyperlipoproteinemia with scanthomatosis: normal lipoprotein markers and the C3 polymorphism.
Berg K, et al.
Cytogenet Cell Genet 12 : 266-270. 1976